Update on the role of the AT2 receptor

被引:95
作者
Carey, RM [1 ]
机构
[1] Univ Virginia, Hlth Syst, Div Endocrinol & Metab, Dept Med, Charlottesville, VA 22908 USA
关键词
angiotensin; angiotensin receptors; bradykin; kidney; nitric oxide; sodium excretion; vasodilation;
D O I
10.1097/00041552-200501000-00011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The renin-angiotensin system is a coordinated hormonal cascade important to the regulation of the renal sodium excretion and blood pressure. The major effector peptide, angiotensin II, binds two major receptors, AT(1) and AT(2). While the majority of angiotensin II actions are mediated via the AT(1) receptor, evidence has accumulated that the AT(2) receptor opposes the AT(1) receptor, especially by inducing vasodilation instead of vasoconstriction. Recent findings During the past year, the evidence for an AT(2) receptor microvascular dilator action has been presented that is mediated by nitric oxide (NO) generation in a bradykinin-dependent or independent manner. Although the AT(2) receptor is expressed in renal proximal and distal tubules and vasculature, and AT(2) receptor stimulation induces a bradykinin/NO pathway within the kidney, little information is available concerning AT(2) receptor regulation of renal function and sodium excretion. From studies reported this year, the AT(2) receptor appears to be protective against ischemic renal injury. Summary The AT(2) receptor represents a potentially important area of investigation with therapeutic applications in the future.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 42 条
[1]  
Akishita M, 2000, PHYSIOL GENOMICS, V2, P13
[2]   AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cells [J].
Andresen, BT ;
Romero, GG ;
Jackson, EK .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01) :425-431
[3]   The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade [J].
Andresen, BT ;
Rizzo, MA ;
Shome, K ;
Romero, G .
FEBS LETTERS, 2002, 531 (01) :65-68
[4]   AT2 receptor stimulation enhances antihypertensive effect of AT1 receptor antagonist in hypertensive rats [J].
Barber, MN ;
Sampey, DB ;
Widdop, RE .
HYPERTENSION, 1999, 34 (05) :1112-1116
[5]   Angiotensin II type 2 receptor - Mediated vasodilation in human coronary microarteries [J].
Batenburg, WW ;
Garrelds, IM ;
Bernasconi, CC ;
Juillerat-Jeanneret, L ;
van Kats, JP ;
Saxena, PR ;
Danser, AHJ .
CIRCULATION, 2004, 109 (19) :2296-2301
[6]   Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors [J].
Bergaya, S ;
Hilgers, RHP ;
Meneton, P ;
Dong, Y ;
Bloch-Faure, M ;
Inagami, T ;
Alhenc-Gelas, F ;
Lévy, BI ;
Boulanger, CM .
CIRCULATION RESEARCH, 2004, 94 (12) :1623-1629
[7]  
BERRY C, 2001, AM J PHYSIOL-HEART C, V281, pH2237
[8]   Angiotensin receptor subtypes in the uterine artery during ovine pregnancy [J].
Burrell, JH ;
Lumbers, ER .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 330 (2-3) :257-267
[9]   Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function [J].
Carey, RM ;
Wang, ZQ ;
Siragy, HM .
HYPERTENSION, 2000, 35 (01) :155-163
[10]   Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats [J].
Carey, RM ;
Howell, NL ;
Jin, XH ;
Siragy, HM .
HYPERTENSION, 2001, 38 (06) :1272-1277